name: 'pdx-model-analysis-agent'
description: 'AI-powered analysis of patient-derived xenograft (PDX) models for drug response prediction, translational research, and personalized treatment selection.'
measurable_outcome: Execute skill workflow successfully with valid output within 15 minutes.
allowed-tools:
- read_file
- run_shell_command
PDX Model Analysis Agent
The PDX Model Analysis Agent provides AI-driven analysis of patient-derived xenograft models for preclinical drug testing, translational research, and personalized oncology. It correlates PDX drug responses with patient outcomes and molecular profiles for treatment selection.
When to Use This Skill
When selecting drug treatments based on PDX drug response data.
To correlate PDX molecular profiles with patient tumor characteristics.
For analyzing PDX-patient concordance in drug sensitivity.
When designing preclinical drug combination studies.
To identify biomarkers predicting PDX and patient drug response.
Core Capabilities
PDX-Patient Concordance: Analyze molecular similarity between PDX and donor tumor.
Drug Response Modeling: ML models correlating PDX drug sensitivity to patient outcomes.
Biomarker Discovery: Identify molecular features predicting drug response in PDX panels.
Combination Screening: Analyze synergy in PDX drug combination studies.
Translational Prediction: Project PDX findings to patient treatment selection.
Quality Assessment: Evaluate PDX fidelity and stability across passages.
PDX Quality Metrics
Metric
Threshold
Interpretation
Genetic concordance
>90%
Variants maintained
Expression correlation
>0.85
Transcriptome preserved
CNV fidelity
>85%
Copy number stable
Tumor take rate
Variable
Engraftment success
Passage stability
<P5 recommended
Minimal drift
Workflow
Input: PDX molecular data, drug response curves, patient tumor data.
Concordance Analysis: Compare PDX to donor tumor at molecular level.
Drug Response Processing: Calculate IC50, AUC, TGI from growth curves.
Biomarker Analysis: Correlate molecular features with drug sensitivity.
Patient Prediction: Project findings to patient treatment recommendations.
Quality Assessment: Flag PDX models with significant drift.
Output: Drug rankings, biomarker associations, treatment recommendations.
Example Usage
User: "Analyze PDX drug response data for this breast cancer patient and recommend treatments."
Biomarker Associations: Features driving sensitivity
Quality Flags: PDX reliability assessment
Treatment Recommendations: Prioritized drug list
Author
AI Group - Biomedical AI Platform
1---2name: pdx-model-analysis-agent3description: <!--4---5<!--6# COPYRIGHT NOTICE7# This file is part of the "Universal Biomedical Skills" project.8# Copyright (c) 2026 MD BABU MIA, PhD <md.babu.mia@mssm.edu>9# All Rights Reserved.10#11# This code is proprietary and confidential.12# Unauthorized copying of this file, via any medium is strictly prohibited.13#14# Provenance: Authenticated by MD BABU MIA1516-->1718---19name: 'pdx-model-analysis-agent'20description: 'AI-powered analysis of patient-derived xenograft (PDX) models for drug response prediction, translational research, and personalized treatment selection.'21measurable_outcome: Execute skill workflow successfully with valid output within 15 minutes.22allowed-tools:23 - read_file24 - run_shell_command25---262728# PDX Model Analysis Agent2930The **PDX Model Analysis Agent** provides AI-driven analysis of patient-derived xenograft models for preclinical drug testing, translational research, and personalized oncology. It correlates PDX drug responses with patient outcomes and molecular profiles for treatment selection.3132## When to Use This Skill3334* When selecting drug treatments based on PDX drug response data.35* To correlate PDX molecular profiles with patient tumor characteristics.36* For analyzing PDX-patient concordance in drug sensitivity.37* When designing preclinical drug combination studies.38* To identify biomarkers predicting PDX and patient drug response.3940## Core Capabilities41421. **PDX-Patient Concordance**: Analyze molecular similarity between PDX and donor tumor.43442. **Drug Response Modeling**: ML models correlating PDX drug sensitivity to patient outcomes.45463. **Biomarker Discovery**: Identify molecular features predicting drug response in PDX panels.47484. **Combination Screening**: Analyze synergy in PDX drug combination studies.49505. **Translational Prediction**: Project PDX findings to patient treatment selection.51526. **Quality Assessment**: Evaluate PDX fidelity and stability across passages.5354## PDX Quality Metrics5556| Metric | Threshold | Interpretation |57|--------|-----------|----------------|58| Genetic concordance | >90% | Variants maintained |59| Expression correlation | >0.85 | Transcriptome preserved |60| CNV fidelity | >85% | Copy number stable |61| Tumor take rate | Variable | Engraftment success |62| Passage stability | <P5 recommended | Minimal drift |6364## Workflow65661. **Input**: PDX molecular data, drug response curves, patient tumor data.67682. **Concordance Analysis**: Compare PDX to donor tumor at molecular level.69703. **Drug Response Processing**: Calculate IC50, AUC, TGI from growth curves.71724. **Biomarker Analysis**: Correlate molecular features with drug sensitivity.73745. **Patient Prediction**: Project findings to patient treatment recommendations.75766. **Quality Assessment**: Flag PDX models with significant drift.77787. **Output**: Drug rankings, biomarker associations, treatment recommendations.7980## Example Usage8182**User**: "Analyze PDX drug response data for this breast cancer patient and recommend treatments."8384**Agent Action**:85```bash86python3 Skills/Oncology/PDX_Model_Analysis_Agent/pdx_analyzer.py \87 --pdx_rnaseq pdx_expression.tsv \88 --pdx_mutations pdx_variants.maf \89 --patient_tumor patient_expression.tsv \90 --drug_responses pdx_drug_panel.csv \91 --tumor_type breast_cancer \92 --concordance_check true \93 --output pdx_recommendations/94```9596## Drug Response Metrics9798| Metric | Calculation | Interpretation |99|--------|-------------|----------------|100| IC50 | Concentration for 50% inhibition | Potency |101| AUC | Area under dose-response curve | Overall sensitivity |102| TGI | Tumor growth inhibition % | In vivo efficacy |103| T/C | Treated/Control volume ratio | Treatment effect |104| Best response | Maximum tumor regression | Depth of response |105106## PDX Resource Integration107108| Resource | Coverage | Data Types |109|----------|----------|------------|110| PDXFINDER | 4000+ models | Multi-omic, drug response |111| PDMR (NCI) | 500+ models | Genomic, drug response |112| Champions/Crown | 1500+ models | Drug response |113| EurOPDX | 1000+ models | European cohort |114115## AI/ML Models116117**Drug Response Prediction**:118- Gradient boosting on multi-omic features119- Gene expression signatures for drug classes120- Mutation-based response predictors121122**PDX-Patient Translation**:123- Transfer learning from PDX to patient124- Domain adaptation for species differences125- Concordance-weighted predictions126127**Combination Synergy**:128- Bliss independence model129- Loewe additivity analysis130- Machine learning synergy prediction131132## Clinical Translation Considerations133134**Factors Affecting Translation**:1351. **Tumor heterogeneity**: PDX from single biopsy1362. **Microenvironment**: Mouse vs human stroma1373. **Immune system**: Immunodeficient hosts1384. **Pharmacokinetics**: Species differences1395. **Passage number**: Drift over time140141**Best Practices**:142- Use early passage PDX (P1-P5)143- Confirm molecular concordance144- Test drug at clinically-relevant doses145- Consider humanized PDX for immunotherapy146147## Prerequisites148149* Python 3.10+150* scikit-learn, pandas151* Drug response databases152* PDX molecular datasets153154## Related Skills155156* Drug_Repurposing - For alternative drug identification157* Multi_Omics_Integration - For PDX characterization158* Clinical_Trials - For trial matching159160## Output Report1611621. **Concordance Summary**: PDX-patient molecular similarity1632. **Drug Rankings**: Predicted efficacy from PDX data1643. **Biomarker Associations**: Features driving sensitivity1654. **Quality Flags**: PDX reliability assessment1665. **Treatment Recommendations**: Prioritized drug list167168## Author169170AI Group - Biomedical AI Platform171172173<!-- AUTHOR_SIGNATURE: 9a7f3c2e-MD-BABU-MIA-2026-MSSM-SECURE -->
Run npx skillmds@latest add biotender-max/pdx-model-analysis-agent in your terminal (requires Node.js), paste this page's agent-chat prompt into Claude, Cursor, or any MCP-connected agent, or download the SKILL.md file and copy it into your agent's skills directory.
<!-- It is listed under AI & ML on SkillMD.
This skill has not completed SkillMD's automated safety review yet. SkillMD never runs a skill's scripts for you; review the SKILL.md before installing.
This skill is tagged as working with Claude Code, Claude.ai, OpenAI Codex. SKILL.md is an open format, so most agents that read a skills directory can load it too.
Yes. Installing skills from SkillMD is free, and the skill stays under its author's original license.
BioTender-max (@biotender-max) published this skill. Their other Agent Skills are listed on their SkillMD profile.